Earn points on every order · Free shipping on orders over $159 · New products in stock
← Back to Compound Library
Cognitive and Neuroprotective

SEMAX (INTRANASAL)

Semax as a nasal spray.

Research referenceCommunity compiled
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Semax as a nasal spray.

What It Does

Approved pharmaceutical in Russia and Ukraine – and stroke recovery. analog stimulating BDNF/NGF synthesis, upregulating serotonin/dopamine receptors, and activating PDGF for neuroprotection.

Reconstitution

Vial SizeBAC Water / SolventConcentration
5 mg+ 5 mL sterile saline1 mg/mL
10 mg+ 10 mL sterile saline1 mg/mL
Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Calculated concentration—Enter both values above.
Optional conversion

Enter a target amount you already have and select the syringe capacity.

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

PhaseFrequencyAmountNotes
StandardDaily AM200–400 mcg1–2 sprays per nostril, alternating sides. 100 µL @ 1 mg/mL = 100 mcg per spray.
HigherDaily AM600 mcg3 sprays per nostril, alternating sides. Or split AM + early afternoon to reduce nasal irritation.
Off1–2 weeks–Tolerance prevention. 5-day-on / 2-day-off variant also community-standard.
Cycle & Timing

2–4 week blocks, 1–2 weeks off.

Timing

AM intranasal, calibrate sprays with the supplier’s nasal pump (standard 100 µL per actuation) before clinical use.

Evidence Context

Russian-approved (stroke/cognition); no Western RCT.

Population Considerations

Unisex nootropic / neuroprotective (intranasal), dose by protocol, no sex effect. Avoid in pregnancy.

Handling & Stacking

Injection site
  • Intranasal: 1–2 sprays per nostril, alternating sides each dose.
  • Use a calibrated nasal pump (100 µL/spray, 100 mcg per spray at this recon) and tilt head slightly back during instillation.
  • For SubQ injection, see the Semax page.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted in saline: 36–46°F.
  • Best used within 21 days.
  • Discard if cloudy or particulate.
  • Community runs Semax nasal spray about ~1–2 weeks in plain saline (or ~3–4 weeks if made with bacteriostatic water) refrigerated at 36–46°F and dark, and it's worth leaning to the shorter end since Semax's N-terminal methionine oxidizes; it's community convention, not published data.
Side effects
Headache (first 1–3 days, resolves). Irritability if stacked with stimulants.
What to expect
  • Mental clarity and focus often within hours of first dose.
  • Sustained cognitive enhancement builds over 2–4 weeks.
  • Brief headache in days 1–3 is normal.
  • Supply math 5mg → 4 vials | 10mg → 2 vials (4-wk @ 600 mcg × 7/wk)
Pairs well with
Selank (anxiolytic + cognitive synergy); BPC-157 (neurorepair); Alpha-GPC or Citicoline (choline source prevents headache)
Avoid
MAOIs. Active psychosis / mania
Approved drug
  • There is no FDA-approved cognitive enhancer, no drug is approved for boosting focus or memory in healthy people (stimulants are approved only for ADHD/narcolepsy).
  • Semax’s Russian approval does not apply in the US.

Safety & Patient Education

Labs
Compound-specific: CBC + CMP baseline; no compound-specific markers routinely required
References
PubMed · thepeptidereport